4//SEC Filing
Domzalski David 4
Accession 0001209191-23-058815
CIK 0001566044other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:08 PM ET
Size
8.1 KB
Accession
0001209191-23-058815
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2023-12-13+225,000→ 271,168 total - Award
Stock Option (right to buy)
2023-12-13+225,000→ 225,000 totalExercise: $2.70Exp: 2033-12-12→ Common Stock (225,000 underlying)
Footnotes (3)
- [F1]Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
- [F3]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727794
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 5:08 PM ET
- Size
- 8.1 KB